Actively Recruiting
Phase III Trial Comparing Maintenance Therapy and Chemotherapy After Surgery for Colorectal Cancer Liver Metastases Guided by ctDNA
Led by Sixth Affiliated Hospital, Sun Yat-sen University · Updated on 2023-04-04
346
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating treatments for patients with colorectal cancer that has spread to the liver and can be surgically removed. The study aims to find out if patients who test positive for circulating tumor DNA ctDNA after surgery have better progression-free survival when given a combination of adjuvant chemotherapy and maintenance therapy compared to adjuvant chemotherapy alone. This is a phase III randomized controlled trial focusing on improving outcomes after surgery by targeting residual cancer cells detected by ctDNA. Participants will undergo colorectal cancer surgery with liver metastasis removal or ablation. After surgery, patients with positive ctDNA results are randomly assigned to receive either standard adjuvant chemotherapy alone or adjuvant chemotherapy combined with maintenance therapy using low-toxicity drugs such as capecitabine or 5-FULV, possibly with targeted therapy. Maintenance treatment continues until ctDNA tests turn negative. The trial compares these two approaches over several years. During the study, participants will be monitored for progression-free survival at 3 and 5 years after surgery, along with overall survival and long-term complications for up to 5 years. Assessments include regular follow-ups to track disease status and safety. The study collects detailed data to understand the benefits and risks of adding maintenance therapy for ctDNA-positive patients after liver metastasis surgery in colorectal cancer.
CONDITIONS
Brief Title
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here